CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding CollPlant Biotechnologies Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 18 | 19 | +1 |
| Shares | 1.88M | 1.52M | −363.2K (−19.3%) |
| Value | $2.53M | $4.08M | +$1.54M (+60.8%) |
New holders (3)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 5,250 | $14.0K | 0.00% |
| Group One Trading, L.P. | 5,000 | $13.4K | 0.00% |
| Royal Bank of Canada | 284 | $1.00K | 0.00% |
Sold out (2)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Anson Funds Management LP | 159,401 | $216.8K |
| Two Sigma Securities, LLC | 10,349 | $14.1K |